Skip to content

Corporate Governance & Certificates

Certificate of Incorporation

Certificate of Incorporation (PDF) 

Corporate Bylaws


Corporate Governance

Board of Directors Guidelines on Significant Corporate Governance Issues (PDF) 

About Allergan Information

Allergan at a Glance 

Committee Charters

Corporate Governance and Compliance Committee Charter (PDF) 
Audit and Finance Committee Charter (PDF) 
Organization and Compensation Committee Charter (PDF) 
Science and Technology Committee Charter (PDF) 

Code of Conduct

Allergan Code of Conduct (PDF) 

On March 17, 2015, Actavis (NYSE:ACT) completed the acquisition of Allergan, creating a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The combined company has broad commercial reach extending across approximately 100 countries and is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team. Learn more about this exciting combination at

Visit Actavis Corporate Governance